VTRS - Viatris Inc Stock Analysis
Viatris Inc (VTRS) is a publicly traded company listed on the NASD. It operates in the Drug Manufacturers - Specialty & Generic industry, part of the broader Healthcare sector. The company has a market capitalization of 16.30B, generates annual revenue of 14.29B, and reports net income of -3.51B. As of the latest data, the stock is trading at 14.16 USD.
From a valuation and risk perspective, the stock presents the following profile: The P/E ratio is unavailable or not meaningful at this time. The PEG ratio is below 1, which may indicate the stock is undervalued relative to its growth potential. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock offers a moderate dividend yield (3.66%), which may appeal to income-focused investors. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.83), indicating current market sentiment. Institutional ownership is reported at 84.52%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 48.90%, trading within a 52-week range of 6.85 - 16.47.
VTRS - Viatris Inc
14.16
Analyst Consensus
Hold 3.83
VTRS – Analyst Rating Summary
- Strong Buy: 4
- Buy: 8
- Hold: 5
- Sell: 1
- Strong Sell: 0
- Total Analysts: 18
| Index: | S&P 500 | P/E: | - | EPS (ttm): | -2.96 | Insider Own: | 2.05% | Shs Outstand: | 1.15B | Perf Week: | -5.16% |
| Market Cap: | 16.30B | Forward P/E: | 5.31 | EPS next Y: | 2.66 | Insider Trans: | -0.03% | Shs Float: | 1.13B | Perf Month: | -1.39% |
| Income(ttm): | -3.51B | PEG: | 0.35 | EPS next Q: | 0.51 | Inst Own: | 84.52% | Short Float: | 2.35% | Perf Quarter: | 30.63% |
| Revenue(ttm): | 14.29B | P/S: | 1.14 | EPS this Y: | 4.69% | Inst Trans: | 0.41% | Short Ratio: | 2.65 | Perf Half Y: | 37.08% |
| Book/sh: | 12.78 | P/B: | 1.11 | EPS next Y: | 8.29% | ROA: | -8.93% | Short Interest: | 26.45M | Perf Year: | 48.90% |
| Cash/sh: | 1.26 | P/C: | 11.21 | EPS next 5Y: | 15.02% | ROE: | -21.08% | 52W Range: | 6.85 - 16.47 | Perf YTD: | 13.73% |
| Dividend Est.: | 0.52 (3.66%) | P/FCF: | 8.42 | EPS past 3/5Y: | - -21.93% | ROIC: | -12.84% | 52W High: | 16.47 -14.03% | Beta: | 0.80 |
| Dividend TTM: | 0.48 (3.39%) | Quick Ratio: | 0.74 | Sales past 3/5Y: | -4.04% 3.66% | Gross Margin: | 38.49% | 52W Low: | 6.85 106.72% | Perf 5Y: | 1.80% |
| Dividend Ex-Date: | Mar 09, 2026 | Current Ratio: | 1.30 | EPS Y/Y TTM: | -456.43% | Oper. Margin: | 7.99% | RSI (14): | 41.67 | Volatility: | 3.44% 3.34% |
| Employees: | 30000 | Debt/Eq: | 1.00 | Sales Y/Y TTM: | -2.61% | Profit Margin: | -24.59% | Recom: | 2.33 | Target Price: | 15.62 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.86 | EPS Q/Q: | 31.80% | Payout: | - | Rel Volume: | 1.08 | Prev Close: | 14.53 |
| Sales Surprise: | 4.85% | EPS Surprise: | 7.08% | Sales Q/Q: | 6.60% | Earnings: | Feb 26 BMO | Avg Volume: | 9.97M | Price: | 14.16 |
| SMA20: | -8.57% | SMA50: | 1.54% | SMA200: | 29.73% | Undervalued: 10.31% | Volume: | 10,820,823 | Change: | -2.55% | |
Graham Classic formula value: -102.44
(P/E=8 * 1g) Min value: -61.19
(current P/E * 2g) Max value: -79.85
Average value: -81.16
About Viatris Inc
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.